Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas
✍ Scribed by E. Ryschich; G. Huszty; H.P. Knaebel; M. Hartel; M.W. Büchler; J. Schmidt
- Book ID
- 116428140
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 833 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A transferrin receptor was demonstrated in tumor tissue from 10 patients with breast carcinoma and one patient with breast sarcoma. Binding studies were conducted by measuring the amount of ^125^I‐transferrin binding to microsomal preparations of the tumor tissue. Elevated levels of spe
By means of the differential display method, we isolated a novel human gene that is expressed specifically in pancreas. The cDNA, designated ''pancpin,'' contained an open reading frame of 1,215 nucleotides encoding a 405 amino acid protein, showing a high degree of similarity to serine protease inh
## Abstract Pancreatic adenocarcinoma has a rising incidence and a very poor survival rate. To develop new treatment strategies, extensive research is performed on animal models of pancreatic cancer. Orthotopic pancreatic tumors models, where the tumor is implanted into the pancreas, resemble the h